Related Experiment Video
Updated: Jul 14, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Pregnancy and thrombophilia.
Mrinal M Patnaik1, Tufia Haddad, Colleen T Morton
1University of Minnesota, Department of Internal Medicine, Minneapolis, MN, USA. patna009@umn.edu
Expert Review of Cardiovascular Therapy
|July 4, 2007
Summary
Pregnancy increases clotting risk, potentially causing complications like miscarriage. Anticoagulant drugs, such as heparin, can prevent these adverse pregnancy outcomes in women with thrombophilia.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Reproductive Medicine
Background:
- Pregnancy naturally induces a hypercoagulable state, crucial for preventing hemorrhage during labor.
- Thrombophilia, hereditary or acquired, disrupts this balance, increasing risks for venous thromboembolism and adverse pregnancy outcomes.
- Adverse outcomes include recurrent pregnancy loss, intrauterine fetal death, growth retardation, preeclampsia, and placental abruption.
Purpose of the Study:
- To review the association between thrombophilias and pregnancy complications.
- To address conflicting data arising from retrospective studies.
- To evaluate the role of anticoagulant therapy in managing thrombophilia during pregnancy.
Main Methods:
- Analysis of existing literature on thrombophilia and pregnancy complications.
- Critique of methodologies in retrospective studies, including lack of randomization and patient population homogeneity.
- Evaluation of data supporting anticoagulant use for prevention.
Main Results:
- Retrospective studies provide conflicting data on screening and treatment due to methodological limitations.
- Limited data suggest anticoagulant drugs are beneficial for preventing pregnancy-related complications in thrombophilic women.
- Heparin and low-molecular-weight heparins are preferred due to placental safety.
Conclusions:
- Anticoagulant therapy, particularly heparin-based treatments, is supported by limited data for preventing adverse pregnancy outcomes in women with thrombophilia.
- Careful consideration of risks and benefits is necessary due to limitations in current research.
- Warfarin use is restricted to specific gestational periods or postpartum due to potential fetal risks.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...